Since TS2/16 recognizes human but not mouse integrin β1, our data suggested that TS2/16 is activating integrin β1 on human A375 cancer cells to induce TME changes in vivo, most likely by increasing the extracellular active-TGF-β levels. Here, TGFB1 is linked to cancer.